|

Immune checkpoint inhibitor Clinical Trials

13 actively recruiting trials across 2 locations

Also known as: 1, AK104, Atezolizumab, Avelumab, Cadonilimab +10 more

Pipeline

Phase 2: 2Phase 3: 2Phase 1/2: 3

Top Sponsors

University of Washington1
Universitaire Ziekenhuizen KU Leuven1
Sun Yat-sen University1
Shanghai Chest Hospital1
Peking Union Medical College Hospital1

Indications

Cancer13
Lung Cancer6
Non Small Cell Lung Cancer4
Breast Cancer2
Exosomal mRNA Expression of PD-L1 and IFNγ1

Other11 trials

A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma

Biomarkers in Immunotherapy of Melanoma

N/A

Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer

Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Phase 3

ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

Phase 2

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

Phase 2

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

Phase 3

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Phase 1/2

Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors

Phase 1/2

Houston, Texas1 trial

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

M D Anderson Cancer Center

Seattle, Washington1 trial

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

Fred Hutch/University of Washington Cancer Consortium

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.